Diastolic dysfunction

There are 223 papers on diastolic dysfunction in aging research: 9 trials and 76 observational studies in people, 105 in animals, 2 in cells, 30 reviews. The newest story, Nov 9, 2026: “Heart-filling problems grew more common in very late life”.

Disease

223 papers study it204 more mention it69 findings

67 new papers in 30 daysSee all 427 papers on diastolic dysfunction

At a glance

Diastolic dysfunction is linked with frailty and higher cardiovascular mortality in human studies of people with preserved ejection fraction, with the mortality association reported in those without valvular disease. In mice with age-dependent dysfunction, rapamycin, caloric restriction and nicotinamide improve diastolic function; DCSL1 prevents dysfunction in aged females but shows no clear effect in aged males.

69 findings in 54 papers from 2006 to 2026, 9 of them since May 2026

“each 1-unit increase in BRI was associated with 14.4% higher odds of DD (OR = 1.144, 95% CI: 1.046-1.251, P = 0.003).”
Association between Body Roundness Index and diastolic function in middle-aged and older adults: a cross-sectional studyFrontiers in cardiovascular medicine2026doi:10.3389/fcvm.2025.1659587
  • Human trial9
  • Humans76
  • Animals103
  • Model organisms2
  • Cells2
  • In silico1

Interventions

22

Decorin

upin mice2

2 studies
  1. Decorin increases diastolic dysfunction in mice.

    “Decorin treatment via osmotic mini pump induced diastolic dysfunction and a pro-inflammatory environment in the myocardium”

    Animalsnon-glycanatedmyocardium

    Ageing-associated endothelial decorin induction and the impact of non-glycanated decorin on cardiac inflammation

    Cardiovascular research

  2. Decorin induces diastolic dysfunction in mice (osmotic mini-pump infusion).

    “Decorin treatment via osmotic mini-pump induced diastolic dysfunction and a pro-inflammatory environment in the myocardium”

    Animalsosmotic mini-pump infusionheart

    Endothelial decorin is increased by ageing and, induces inflammation and diastolic dysfunction in the heart

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

More on Decorin

Empagliflozin

no changein human cells1downin mice1

2 studies
  1. Empagliflozin showed no clear effect on diastolic dysfunction in endothelin-1 and TGF-β-induced diastolic dysfunction HOCs.

    “While empagliflozin treatment had no effect on DD HOCs”

    Cellsin endothelin-1 and TGF-β-induced diastolic dysfunction HOCscardiac microtissue

    Human heart-on-a-chip model emulates structural and functional characteristics of diastolic dysfunction and reveals a beneficial role for senolytics

    Acta biomaterialia

  2. Empagliflozin decreases diastolic dysfunction in high-fat diet-fed mice.

    “EMPA administration effectively ameliorated metabolic disorders and cardiac diastolic dysfunction in HFD-fed mice.”

    Animalsin high-fat diet-fed mice8 weeksmales

    Empagliflozin alleviates obesity-related cardiac dysfunction via the activation of SIRT3-mediated autophagosome formation

    Lipids in health and disease

More on Empagliflozin

Dasatinib + quercetin

downin human cells1downin mice1

2 studies
  1. Dasatinib + quercetin decreases diastolic dysfunction in endothelin-1 and TGF-β-induced diastolic dysfunction HOCs.

    “treatment with dasatinib and quercetin (D+Q) or with ranolazine (RAN) partially reversed the disease phenotype”

    Cellsin endothelin-1 and TGF-β-induced diastolic dysfunction HOCscardiac microtissue

    Human heart-on-a-chip model emulates structural and functional characteristics of diastolic dysfunction and reveals a beneficial role for senolytics

    Acta biomaterialia

  2. Dasatinib + quercetin decreases diastolic dysfunction in the hearts of obese mice.

    “repressing cardiac hypertrophy, and improving diastolic dysfunction”

    Animalsin the hearts of obese miceheart

    Senescent cell depletion alleviates obesity-related metabolic and cardiac disorders

    Molecular metabolism

More on Dasatinib + quercetin

Nicotinamide

downin mice1downin rats1

1 study
  1. Nicotinamide decreases diastolic dysfunction in rats (diastolic dysfunction induced by hypertension in Dahl salt-sensitive rats).

    “Elevating NAD+ by oral supplementation of its precursor, nicotinamide, improved diastolic dysfunction induced by aging (in 2-year-old C57BL/6J mice), hypertension (in Dahl salt-sensitive rats)”

    Animalsdiastolic dysfunction induced by hypertension in Dahl salt-sensitive rats

    Nicotinamide for the treatment of heart failure with preserved ejection fraction

    Science translational medicine

  2. Nicotinamide decreases diastolic dysfunction in mice (diastolic dysfunction induced by aging).

    “Elevating NAD+ by oral supplementation of its precursor, nicotinamide, improved diastolic dysfunction induced by aging (in 2-year-old C57BL/6J mice)”

    Animalsdiastolic dysfunction induced by aging

    Nicotinamide for the treatment of heart failure with preserved ejection fraction

    Science translational medicine

More on Nicotinamide

DCSL1

no changein mice1downin mice1

1 study
  1. DCSL1 showed no clear effect on diastolic dysfunction in mice (aged mice).

    “DCSL1 prevented the worsening of diastolic dysfunction over time in females but not in males.”

    Animalsaged miceheart12 weeksmales

    Treatment with a DC-SIGN ligand reduces macrophage polarization and diastolic dysfunction in the aging female but not male mouse hearts

    GeroScience

  2. DCSL1 prevents diastolic dysfunction in mice (aged mice).

    “DCSL1 prevented the worsening of diastolic dysfunction over time in females but not in males.”

    Animalsaged miceheart12 weeksfemales

    Treatment with a DC-SIGN ligand reduces macrophage polarization and diastolic dysfunction in the aging female but not male mouse hearts

    GeroScience

More on DCSL1

AP20187

downin mice1

1 study
  1. AP20187 decreases diastolic dysfunction in vehicle-treated aged mice with p16-positive cell clearance.

    “Diastolic dysfunction in vehicle mice normalized with AP treatment.”

    Animalsin vehicle-treated aged mice with p16-positive cell clearanceheart

    Clearance of p16-positive cardiac cells improves age-related cardiac remodeling in mice

    Experimental physiology

More on AP20187

Atorvastatin

downin mice1

1 study
  1. Atorvastatin protects against diastolic dysfunction in HIV- and ART-treated mice.

    “Mice depleted of platelet TGF-β1 or treated with atorvastatin were partially protected from HIV- and ART-induced cardiac fibrosis, steatosis, and diastolic dysfunction.”

    Animalsin HIV- and ART-treated mice

    Atorvastatin suppresses HIV/antiretroviral drug-induced cardiac fibrosis and dysfunction in mice by blocking platelet TGF-β1 signaling

    JCI insight

More on Atorvastatin

Pioglitazone

downin humans1

1 study
  1. Pioglitazone decreases diastolic dysfunction in humans (hypertension).

    “The drug modulates neurohormonal pathways and improves diastolic dysfunction in hypertensive patients.”

    Reviewhypertensionheart

    Fluid retention versus cardio protection: rethinking pioglitazone

    Annals of medicine and surgery (2012)

More on Pioglitazone

Ranolazine

downin human cells1

1 study
  1. Ranolazine decreases diastolic dysfunction in endothelin-1 and TGF-β-induced diastolic dysfunction HOCs.

    “treatment with dasatinib and quercetin (D+Q) or with ranolazine (RAN) partially reversed the disease phenotype”

    Cellsin endothelin-1 and TGF-β-induced diastolic dysfunction HOCscardiac microtissue

    Human heart-on-a-chip model emulates structural and functional characteristics of diastolic dysfunction and reveals a beneficial role for senolytics

    Acta biomaterialia

More on Ranolazine

VEGFB186 gene transfer

downin mice1

1 study
  1. VEGFB186 gene transfer prevents diastolic dysfunction in mice (age-induced, in aged hearts after AAV9 delivery).

    “doses of Vegfb186 overexpression that had only a modest effect on the vascular endothelium prevented age-induced diastolic dysfunction and fibrosis”

    Animalsage-induced, in aged hearts after AAV9 deliveryAAV9-mediated overexpression of Vegfb186heartmales

    Beneficial effects of vascular endothelial growth factor B gene transfer in the aged heart

    Cardiovascular research

More on VEGFB186 gene transfer

All 22

Upstream

10

Trimethylamine N-oxide

upin mice1

1 study
  1. Trimethylamine N-oxide increases diastolic dysfunction in mice (intraperitoneal TMAO injection in young mice).

    “Starting from 2 months of TMAO treatment, impairment of cardiac diastolic function and progression of cardiac fibrosis were observed alongside the upregulation of senescence marker proteins expression.”

    Animalsintraperitoneal TMAO injection in young miceheartfrom 2 months of treatmentmales

    Trimethylamine N-oxide drives cardiac aging by activating NLRP3-mediated pyroptosis

    Life sciences

More on Trimethylamine N-oxide

Oxidative stress markers

no changein humans1

1 study
  1. Oxidative stress markers were not clearly linked with diastolic dysfunction in patients with MASLD and obesity.

    “oxidative stress markers were not associated with diastolic dysfunction or steatosis severity”

    Humansin patients with MASLD and obesityn = 73

    Abdominal Obesity, Hepatic Steatosis, Oxidative Stress and Diastolic Dysfunction in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease

    International journal of molecular sciences

More on Oxidative stress markers

PADI2

downin mice1

1 study
  1. PADI2 protects against diastolic dysfunction in mice (shown by knockout).

    “loss of PAD2 resulted in diastolic dysfunction.”

    Animalsshown by knockoutheartfemales

    Cardiac PAD2 expression and myocardial citrullination decline with age in female mice independent of estrogen

    American journal of physiology. Heart and circulatory physiology

More on PADI2

SIRT6

downin mice1

1 study
  1. SIRT6 decreases diastolic dysfunction in mice (endothelial SIRT6 restoration in diabetic mice).

    “genetically restoring endothelial SIRT6 expression in the diabetic mice ameliorated diastolic dysfunction concurrently with decreased cardiac lipid accumulation”

    Animalsendothelial SIRT6 restoration in diabetic mice

    SIRT6 Mitigates Heart Failure With Preserved Ejection Fraction in Diabetes

    Circulation research

More on SIRT6

Advanced age

upin mice1

1 study
  1. advanced age increases diastolic dysfunction in mice (compared with naked mole-rats, which showed no increase).

    “Magnetic resonance and ultrasound imaging showed age-dependent increases in cardiac hypertrophy and diastolic dysfunction in mice which were absent in NMRs.”

    Animalscompared with naked mole-rats, which showed no increaseheart

    Naked mole-rats maintain cardiac function and body composition well into their fourth decade of life

    GeroScience

PAK1

downin mice1

1 study
  1. PAK1 protects against diastolic dysfunction in mice (shown by knockout in middle-aged female mice).

    “Compared to WT controls, middle-aged PAK1-/- female mice demonstrated worsening of cardiac function involving a greater enlargement of the left atrium, ventricular hypertrophy, and diastolic dysfunction.”

    Animalsshown by knockout in middle-aged female miceheartfemales

    Deletion of P21-activated kinase-1 induces age-dependent increased visceral adiposity and cardiac dysfunction in female mice

    Molecular and cellular biochemistry

More on PAK1

SESN2

downin mice1

1 study
  1. SESN2 protects against diastolic dysfunction in mice (shown by knockout; during ischemia and reperfusion).

    “The results demonstrated that Sesn2 deficiency leads to aging-like cardiac diastolic dysfunction and intolerance to ischemia reperfusion stress.”

    Animalsshown by knockout; during ischemia and reperfusionheart

    Sestrin2 maintains OXPHOS integrity to modulate cardiac substrate metabolism during ischemia and reperfusion

    Redox biology

More on SESN2

SIRT1

downin mice1

1 study
  1. SIRT1 protects against diastolic dysfunction in mice (shown by cardiomyocyte Sirt1 deficiency; SFA-rich high-fat diet).

    “worsened left ventricular (LV) diastolic function in mice fed an SFA-rich high fat diet”

    Animalsshown by cardiomyocyte Sirt1 deficiency; SFA-rich high-fat dietheart

    Sirt1 counteracts decrease in membrane phospholipid unsaturation and diastolic dysfunction during saturated fatty acid overload

    Journal of molecular and cellular cardiology

More on SIRT1

Left ventricular fibrosis, stiffness, and wall thickness

upin reviews1

1 study
  1. Left ventricular fibrosis, stiffness, and wall thickness increases diastolic dysfunction (age-dependent cardiac changes).

    “Age-dependent increases in left ventricular fibrosis, stiffness, and wall thickness promote diastolic dysfunction”

    Reviewage-dependent cardiac changesleft ventricle

    Sex Differences in the Biology and Pathology of the Aging Heart

    The Canadian journal of cardiology

MT1

downin mice1

1 study
  1. MT1 protects against diastolic dysfunction in mice (aged cardiomyocytes).

    “aged myocytes displayed prolonged TR(90), reduced tolerance to high stimulus frequency, and slowed intracellular Ca2+ decay, all of which were nullified by metallothionein”

    Animalsaged cardiomyocytesheart

    Metallothionein prolongs survival and antagonizes senescence-associated cardiomyocyte diastolic dysfunction: role of oxidative stress

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology

More on MT1

Associations

30

Controlled attenuation parameter

upin humans1

1 study
  1. Controlled attenuation parameter is associated with diastolic dysfunction in humans (adjusted for age and sex, lost after adjustment for waist circumference).

    “CAP was independently associated with diastolic dysfunction after adjustment for age and sex, but this association was lost after further adjustment for waist circumference”

    Humansadjusted for age and sex, lost after adjustment for waist circumferencen = 73

    Abdominal Obesity, Hepatic Steatosis, Oxidative Stress and Diastolic Dysfunction in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease

    International journal of molecular sciences

  2. Diastolic dysfunction is associated with controlled attenuation parameter in patients with MASLD and obesity.

    “Markers of hepatic steatosis, including fatty liver index (FLI) and controlled attenuation parameter (CAP), were higher in patients with diastolic dysfunction”

    Humansin patients with MASLD and obesityn = 73

    Abdominal Obesity, Hepatic Steatosis, Oxidative Stress and Diastolic Dysfunction in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease

    International journal of molecular sciences

More on Controlled attenuation parameter

Cardiac macrophage abundance

upin humans1upin mice1

1 study
  1. Diastolic dysfunction is associated with cardiac macrophage abundance in humans (diastolic dysfunction).

    “cardiac macrophages expand in humans and mice with diastolic dysfunction”

    Humansdiastolic dysfunctionmyocardium

    Cardiac macrophages promote diastolic dysfunction

    The Journal of experimental medicine

  2. Diastolic dysfunction is associated with cardiac macrophage abundance in mice (diastolic dysfunction induced by hypertension or advanced age).

    “cardiac macrophages expand in humans and mice with diastolic dysfunction”

    Animalsdiastolic dysfunction induced by hypertension or advanced agemyocardium

    Cardiac macrophages promote diastolic dysfunction

    The Journal of experimental medicine

More on Cardiac macrophage abundance

Clonal hematopoiesis of indeterminate potential

upin humans1

1 study
  1. Clonal hematopoiesis of indeterminate potential is associated with diastolic dysfunction in humans (patients undergoing treatment for solid tumors) (Median time to diastolic dysfunction: 17.5 days with CHIP versus 18.0 days without CHIP).

    “CHIP was an independent risk factor for diastolic dysfunction (p-value 0.021)”

    Humanspatients undergoing treatment for solid tumorsheartn = 236

    Clonal hematopoiesis of indeterminate potential (CHIP) is associated with increased risk of diastolic dysfunction in a cardio-oncology cohort

    ESC Congress 2026 abstract

More on Clonal hematopoiesis of indeterminate potential

TET2

upin humans1

1 study
  1. TET2 is associated with diastolic dysfunction in humans.

    “TET2 mutations, in particular, have been consistently linked to diastolic dysfunction and adverse remodeling, especially in patients with high inflammatory burden and cardiometabolic comorbidities.”

    ReviewTET2 mutations, especially in patients with high inflammatory burden and cardiometabolic comorbiditiesheart

    Clonal Hematopoiesis and Inflammatory Pathways in Heart Failure with Preserved Ejection Fraction

    Current heart failure reports

More on TET2

Physical activity

upin humans1OR 8.246

1 study
  1. Physical activity is linked with a higher risk of diastolic dysfunction in humans after adjustment, compared to Group B (4-12 h/week) (OR = 8.246, 95% CI: 2.118-32.096).

    “After adjustment, Group C had higher odds of being classified as having diastolic dysfunction than Group B (OR = 8.246; 95% CI: 2.118-32.096; p = 0.002).”

    Humansafter adjustment, compared to Group B (4-12 h/week)>12 h/weekn = 84

    Association Between Self-Reported Weekly Physical Activity Duration and Echocardiographic Cardiac Structure and Function in Adults Aged ≥ 45 Years: A Cross-Sectional Study

    Journal of cardiovascular development and disease

More on Physical activity

Systolic blood pressure

upin humans1

1 study
  1. Systolic blood pressure is associated with diastolic dysfunction in humans (Multivariate analysis) (aOR 1.03, 95% CI 1.01–1.05).

    “systolic blood pressure (aOR 1.03, 95% CI 1.01-1.05; p = 0.001) were independently associated with DD, whereas CRF burden was not.”

    HumansMultivariate analysisn = 345

    Cumulative cardiovascular risk factor burden is independently associated with impaired global longitudinal strain in individuals with preserved ejection fraction: a Vietnamese cross-sectional study

    BMC cardiovascular disorders

More on Systolic blood pressure

Age ≥60 years

upin humans1

1 study
  1. Age ≥60 years are associated with diastolic dysfunction in humans (Multivariate analysis) (aOR 5.80, 95% CI 2.80–12.01).

    “only age ≥ 60 years (aOR 5.80, 95% CI 2.80-12.01; p = 0.001)”

    HumansMultivariate analysisn = 345

    Cumulative cardiovascular risk factor burden is independently associated with impaired global longitudinal strain in individuals with preserved ejection fraction: a Vietnamese cross-sectional study

    BMC cardiovascular disorders

Waist circumference

upin humans1

1 study
  1. Waist circumference predicts diastolic dysfunction in humans (independent of BMI and traditional risk factors).

    “The Baltimore Longitudinal Study of Aging (BLSA) showed that WC predicts diastolic dysfunction independent of BMI and traditional risk factors.”

    Reviewindependent of BMI and traditional risk factors

    Waist Circumference as a Cardiometabolic Vital Sign: A Translational Framework for Early Detection and Prevention of Heart Failure with Preserved Ejection Fraction in Primary Care

    Journal of Obesity and Chronic Diseases

More on Waist circumference

Triglyceride-glucose waist circumference index

upin humans1OR 1.002

1 study
  1. Triglyceride-glucose waist circumference index is linked with a higher risk of diastolic dysfunction in humans (fully adjusted for demographics, blood pressure, and clinical comorbidities) (OR 1.002, 95% CI: 1.001-1.004).

    “TyG-WC was independently associated with an increased risk of DD (OR = 1.002, 95% CI: 1.001-1.004, P < 0.001).”

    Humansfully adjusted for demographics, blood pressure, and clinical comorbidities

    Linear dose-response relationship between TyG-WC index and diastolic dysfunction: insights from restricted cubic spline and machine learning analysis

    Frontiers in endocrinology

More on Triglyceride-glucose waist circumference index

Nitric oxide imbalance

upin reviews1

1 study
  1. nitric oxide imbalance predicts diastolic dysfunction.

    “uncoupled perfusion and energy metabolism, together with nitric oxide imbalance, can serve as early indicators of diastolic dysfunction and ischemic susceptibility”

    Review

    Understanding cardiovascular aging as a disorder of mitochondrial network

    The journal of cardiovascular aging

All 30

Trial sponsors

Funding

11 grants since 2018

National Institute on Aging$1MNational Heart, Lung, and Blood Institute$3.7MGouvernement du Canada | Canadian Institutes of Health ResearchCA$2K

How this record changed

  1. Summary written from the findings.

Latest

Dec 2025: 8Jan 2026: 19Feb 2026: 14Mar 2026: 7Apr 2026: 7May 2026: 8Jun 2026: 7Jul 2026: 8Aug 2026: 9Sep 2026: 15Oct 2026: 45Nov 2026: 24171 papers in 12 months
AHA Scientific Sessions 2026 Abstract

Heart-filling problems grew more common in very late life

The share with heart-filling problems involving elevated pressure rose from 3% to 24% over an average of 13 years.The share with heart-filling problems involving elevated pressure rose from 3% to 24% over an average of 13 years.

Cohort · 811 peoplePopulations
AHA Scientific Sessions 2026 Abstract

Combined blood marker not linked to worsening heart relaxation

Heart-relaxation problems worsened in 6.5%, 8.2% and 8.5% of participants across increasing thirds of an index combining fasting blood sugar and blood fats.Heart-relaxation problems worsened in 6.5%, 8.2% and 8.5% of participants across increasing thirds of an index combining fasting blood sugar and blood fats.

Cohort · 1,205 peopleBiomarkers
AHA Scientific Sessions 2026 Abstract

Blocking a collagen-linking enzyme improved heart failure in rats

Male rats with heart failure had heart relaxation times of 25.24 milliseconds with the inhibitor, compared with 27.20 milliseconds without it.Male rats with heart failure had heart relaxation times of 25.24 milliseconds with the inhibitor, compared with 27.20 milliseconds without it.

Rat studyMechanisms
AHA Scientific Sessions 2026 Abstract

Heart tracing model flagged higher risk of an irregular heartbeat

Seven-year rates of atrial fibrillation, an irregular heartbeat, were 6.4% in people flagged by an artificial intelligence heart-tracing model, versus 2.1% in those not…Seven-year rates of atrial fibrillation, an irregular heartbeat, were 6.4% in people flagged by an artificial intelligence heart-tracing model, versus 2.1% in those not flagged.

Cohort · 43,394 peopleBiomarkers
AHA Scientific Sessions 2026 Abstract

Blocking activin signals improved heart filling in mice

Removing two activin receptor types from certain immune cells lowered a heart-filling pressure index to 31.93, versus 42.99 in heart-failure mice.Removing two activin receptor types from certain immune cells lowered a heart-filling pressure index to 31.93, versus 42.99 in heart-failure mice.

Mouse studyMechanisms

See all 427 papers on diastolic dysfunction